Actively Recruiting
Phase 3
All Genders
NCT04217512
Pantoprazole in Cisplatin Nephrotoxicity
Led by Sherief Abd-Elsalam · Updated on 2020-01-03
60
Participants Needed
1
Research Sites
608 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Pantoprazole in Cisplatin Nephrotoxicity
CONDITIONS
Official Title
Pantoprazole in Cisplatin Nephrotoxicity
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- Patients with head and neck cancer
You will not qualify if you...
- Glomerular filtration rate (GFR) less than 59
- Diabetes mellitus (DM)
- Liver enzymes elevated more than three times the normal level
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Trial Site Locations
Total: 1 location
1
Sherief Abd-Elsalam
Tanta, Egypt
Actively Recruiting
Loading map...
Research Team
S
Sherief Abd-Elsalam, ass. prof.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here